| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 536.64B | 507.60B | 489.01B | 435.79B | 361.50B |
| Gross Profit | 163.73B | 151.31B | 140.10B | 108.04B | 90.52B |
| EBITDA | 104.16B | 100.82B | 90.53B | 59.77B | 47.09B |
| Net Income | 70.19B | 62.87B | 55.65B | 33.13B | 22.41B |
Balance Sheet | |||||
| Total Assets | 642.88B | 594.98B | 570.99B | 497.08B | 454.67B |
| Cash, Cash Equivalents and Short-Term Investments | 261.78B | 257.47B | 254.71B | 186.01B | 177.92B |
| Total Debt | 3.28B | 3.40B | 3.56B | 3.75B | 3.95B |
| Total Liabilities | 98.95B | 101.33B | 96.46B | 92.33B | 87.52B |
| Stockholders Equity | 530.90B | 481.19B | 462.32B | 392.18B | 354.88B |
Cash Flow | |||||
| Free Cash Flow | 43.32B | 49.01B | 51.84B | 28.66B | 20.66B |
| Operating Cash Flow | 85.16B | 78.78B | 70.50B | 42.03B | 33.29B |
| Investing Cash Flow | -45.03B | -40.06B | -53.74B | -25.20B | -27.31B |
| Financing Cash Flow | -43.76B | -43.54B | -12.71B | -9.62B | -9.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥1.14T | 15.47 | 13.07% | 1.82% | 5.72% | 13.87% | |
71 Outperform | ¥4.82T | 36.93 | 9.46% | 1.32% | 3.47% | 99.65% | |
65 Neutral | ¥403.05B | 14.57 | 10.18% | 2.56% | 5.09% | 10.53% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ¥1.03T | 29.10 | 5.97% | 2.96% | 1.70% | -30.43% | |
56 Neutral | ¥571.17B | 14.42 | 6.04% | 2.04% | 6.34% | 38.64% | |
53 Neutral | ¥789.26B | 16.84 | 9.77% | 2.41% | 1.49% | -14.54% |